Physician profile
Patrick J Steinauer
NPI 1801951348
$1,118.78
in general payments reported to CMS, 2019-2025
17 companies · $115 in 2025
The $115 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.64 · 2020: $29.09 · 2021: $284 · 2022: $226 · 2023: $250 · 2024: $130 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $528.74 | 2021-2025 | Qelbree, Qelbree |
| Pfizer INC. | $238.95 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $54.73 | 2022-2025 | Vaxneuvance, Proquad, Gardasil 9 |
| Novartis Pharmaceuticals Corporation | $47.21 | 2019 | |
| Seqirus USA INC | $42.78 | 2021-2023 | Flucelvax Quadrivalent |
| Glaxosmithkline, LLC. | $25.64 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $23.50 | 2023 | Flumist Quadrivalent |
| Sanofi-Aventis U.S. LLC | $22.00 | 2024 | |
| Kaleo, INC. | $20.65 | 2023 | Auvi-Q |
| Ironshore Pharmaceuticals INC. | $17.04 | 2020 | |
| Acadia Pharmaceuticals INC | $16.94 | 2025 | Daybue |
| Tris Pharma INC | $15.96 | 2021 | |
| Genentech USA, INC. | $14.67 | 2022 | |
| Collegium Pharmaceutical, INC. | $13.46 | 2025 | Jornay Pm |
| Alk-Abello, INC | $12.99 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, Lp | $12.05 | 2020 | |
| Vertical Pharmaceuticals, LLC | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Steinauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.